Complement activation by IgM autoantibodies linked to immune-mediated neuropathies depends on C2

Complement factor C2 is a potential therapeutic target in immune-mediated neuropathies. However, literature suggests that classical complement pathway activation may proceed to C3 in the absence of C2, a so-called "C2 bypass." Here, we evaluated a C2 bypass mechanism during complement acti...

Ausführliche Beschreibung